HighTower Advisors LLC cut its stake in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 7.5% in the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 119,361 shares of the semiconductor company’s stock after selling 9,657 shares during the quarter. HighTower Advisors LLC owned approximately 0.06% of Synopsys worth $53,243,000 as of its most recent filing with the SEC.
Several other institutional investors and hedge funds also recently made changes to their positions in the company. BlackRock Inc. bought a new stake in Synopsys during the 2nd quarter worth approximately $7,228,099,000. Mitsubishi UFJ Asset Management Co. Ltd. bought a new stake in shares of Synopsys during the second quarter worth $747,400,000. Norges Bank bought a new stake in shares of Synopsys during the fourth quarter worth $730,197,000. Bank of New York Mellon Corp acquired a new stake in shares of Synopsys in the second quarter valued at $692,074,000. Finally, State Street Corp increased its stake in shares of Synopsys by 20.6% in the third quarter. State Street Corp now owns 8,760,358 shares of the semiconductor company’s stock valued at $4,322,273,000 after buying an additional 1,493,912 shares in the last quarter. Institutional investors and hedge funds own 85.47% of the company’s stock.
Synopsys Price Performance
Shares of SNPS stock opened at $393.84 on Tuesday. The stock has a 50-day moving average price of $411.20 and a 200 day moving average price of $439.29. The company has a quick ratio of 1.24, a current ratio of 1.34 and a debt-to-equity ratio of 0.29. The firm has a market cap of $75.48 billion, a price-to-earnings ratio of 69.58, a PEG ratio of 2.16 and a beta of 1.23. Synopsys, Inc. has a 12 month low of $366.00 and a 12 month high of $615.79.
Wall Street Analyst Weigh In
SNPS has been the topic of several research reports. Citigroup upped their price target on shares of Synopsys from $600.00 to $610.00 and gave the stock a “buy” rating in a research report on Thursday, May 28th. Weiss Ratings raised shares of Synopsys from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, August 27th. Mizuho reduced their target price on shares of Synopsys from $600.00 to $550.00 and set an “outperform” rating on the stock in a research report on Thursday, August 27th. Berenberg Bank set a $633.00 price target on shares of Synopsys in a research note on Wednesday, May 27th. Finally, Bank of America raised their price target on shares of Synopsys from $515.00 to $600.00 and gave the company a “buy” rating in a report on Thursday, May 28th. Twelve investment analysts have rated the stock with a Buy rating, five have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, Synopsys has a consensus rating of “Moderate Buy” and an average price target of $561.28.
Read Our Latest Research Report on Synopsys
Insider Activity at Synopsys
In other Synopsys news, CFO Shelagh Glaser sold 3,394 shares of the stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $450.02, for a total value of $1,527,367.88. Following the transaction, the chief financial officer owned 14,358 shares of the company’s stock, valued at approximately $6,461,387.16. This represents a 19.12% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of the firm’s stock in a transaction dated Monday, June 15th. The stock was sold at an average price of $458.96, for a total value of $6,702,192.88. Following the transaction, the chief executive officer owned 75,020 shares in the company, valued at approximately $34,431,179.20. This trade represents a 16.29% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last quarter, insiders sold 92,638 shares of company stock worth $40,747,732. 0.56% of the stock is owned by insiders.
About Synopsys
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front?end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape?out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
See Also
- Five stocks we like better than Synopsys
- 3 Under-the-Radar Defense Stocks With Record Backlogs
- This Korea ETF Has Soared, But the Rally May Not Be Over
- Why Guidewire’s Post-Earnings Plunge May Not Last
- Ride-Share Reckoning: Tesla Drives Into Uber’s Lane
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
